Lipocine stockholders approve sixth amended 2014 stock incentive plan
Lipocine Inc. received stockholder approval on June 3, 2026 for an amended and restated equity compensation plan designed to attract and retain employees and executives. The plan update allows the company to offer stock-based incentives including options, restricted stock, and other awards to align employee interests with shareholder value.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day